Loading clinical trials...

Individualized Prevention Strategy for High Risk Patients in Cardiovascular Disease: Prospective Cohort Study (Cardiovascular and Metabolic Disease Etiology Research Center - HIgh Risk Cohort) CMERC-HI | Clinical Trials | Clareo Health

UNKNOWN

Individualized Prevention Strategy for High Risk Patients in Cardiovascular Disease: Prospective Cohort Study (Cardiovascular and Metabolic Disease Etiology Research Center - HIgh Risk Cohort) CMERC-HI

NCT02003781•Yonsei University

View on ClinicalTrials.gov

Summary

Set the prospective cohort (CMERC-HI) to study the known and novel etiologies and related factors for predicting clinical outcomes in Korean patients with high risk cardiovascular disease.

Eligibility

Age

20 - 80 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•high risk hypertension patients a. eGFR \> 60 with one of target organ damages b. eGFR \<= 60
•diabetes mellitus with microalbumin ration (AC ratio \>= 30mg/g)
•anuric ESRD patients on dialysis
•the relatives of acute myocardial infarction patients under 55 years old (men)/ 65 years old (women)
•atherosclerotic cardiovascular disease (abdominal aorta diameter ≥3 cm or ankle-brachial index \<0.9, or carotid plaque or carotid intima-media thickness ≥0.9 mm, or asymptomatic old cerebrovascular accident, or \>30% stenosis in at least one major coronary artery)
•rheumatoid arthritis patients aged \> 40 years on MTX and steroid therapy
•atrial fibrillation patients with CHADS-VASc Score ≥ 1
•kidney transplant recipient at \> 3 months after transplantation

Exclusion Criteria

•acute myocardial infarction, acute coronary syndrome patients, symptomatic coronary artery disease or history of these diseases
•symptomatic peripheral artery disease, heart failure and history of these diseases
•desired life time under 6 months due to non-cardiovascular disease (e.g. cancer, sepsis)
•women with pregnancy or on nursing
•history of contrast allergy and related side effects
•within the first three months after transplantation
•acute renal allograft rejection

Locations (1)

Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine

Seoul, South Korea

Key Dates

Start Date

October 1, 2013

Primary Completion Date

October 1, 2023

Completion Date

October 1, 2023

Last Updated

July 17, 2018

Enrollment

4,000

ESTIMATED participants

Conditions

High Risk Cardiovascular Disease Patients

Contacts

Sungha Park, MD

CONTACT

82-2-2228-8455 shpark0530@yuhs.ac